Products

Evonik VESTAMID® Care ME40 Medical Grade Nylon 12

    • Product Name: Evonik VESTAMID® Care ME40 Medical Grade Nylon 12
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications
    HS Code 252708
    Polymer Type Polyamide 12 (Nylon 12)
    Density 1.01 g/cm³
    Shore D Hardness 40
    Tensile Modulus 200 MPa
    Tensile Stress At Yield 20 MPa
    Elongation At Break 300%
    Flexural Modulus 180 MPa
    Melting Point 170 °C
    Vicat Softening Temperature 55 °C
    Water Absorption 1.0%
    Melt Volume Rate 20 cm³/10 min (190°C / 5 kg)
    Biocompatibility ISO 10993 compliant

    As an accredited Evonik VESTAMID® Care ME40 Medical Grade Nylon 12 factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Supplied as 25 kg sealed drums or moisture-protected bags of nylon 12 pellets, with certificate of analysis, ready for medical processing.
    Container Loading (20′ FCL) 20' FCL container loading of Evonik VESTAMID Care ME40 Medical Grade Nylon 12, packed in sealed drums, secured and ventilated.
    Shipping Evonik VESTAMID® Care ME40 medical-grade nylon 12 ships in sealed, moisture-proof containers to preserve purity and performance. Store in a cool, dry area away from direct sunlight and extreme temperatures. Handle with clean, dry equipment to prevent contamination. Ensure packaging remains intact to maintain medical-grade integrity until use.
    Storage Store VESTAMID® Care ME40 in its original, sealed container in a cool, dry area away from direct sunlight, heat sources, and excessive humidity. Keep the packaging tightly closed after each use, as nylon 12 absorbs moisture, which can affect processing and performance. Under these conditions, the material typically maintains its specified properties within its shelf life.
    Shelf Life Shelf life is typically 2 years when stored in original, unopened packaging under cool, dry conditions.
    Application of Evonik VESTAMID® Care ME40 Medical Grade Nylon 12

    Distal microcatheter shafts require a combination of low flexural modulus, moisture-independent dimensional stability, and thin-wall roundness. VESTAMID® Care ME40 is extrusion-compounded from a plasticised medium-viscosity PA12 base; tensile modulus and tensile strength per ISO 527-1/-2 are used to calculate pushability and trackability. The resin must be pre-dried in a desiccant-air hopper at 80 °C for 4 h to 6 h; target moisture content is ≤0.10 wt% and the drying-air dew point is maintained at or below -40 °C. A 25 mm to 30 mm single-screw extruder with a barrier screw, L/D 24:1 to 30:1, and a 100/200/100 mesh breaker plate is used; melt temperature set points are 200 °C to 230 °C from feed to metering, die head 215 °C to 230 °C, and melt pressure before the die 80 bar to 150 bar. Drawdown ratio is held within 1.05 to 1.20; water quenching and vacuum sizing at 20 °C to 40 °C generate a single-lumen shaft with a target outer diameter of 0.85 mm ± 0.02 mm and inner diameter of 0.55 mm ± 0.02 mm, with wall concentricity continuously measured on 2 axes by ultrasonic wall-thickness sensors. When radiopaque filler is required, barium sulfate is compounded into the resin at 10 wt% to 20 wt% in a twin-screw extruder with L/D 36:1 to 44:1, barrel temperatures 200 °C to 240 °C, screw speed 200 rpm to 400 rpm, and vacuum devolatilisation at 200 mbar to 400 mbar; filler dispersion is checked by melt filtration and cross-sectional microscopy because agglomerates can create point defects in a 0.10 mm wall. Melt temperatures above 240 °C cause surface yellowing and elongation loss through plasticiser volatilisation; the same constraint applies to the compounding stage. The finished shaft is validated under ISO 10555-1 for catheter mechanical performance, ISO 10993-5 for cytotoxicity, ISO 10993-10 for irritation and sensitisation, and USP <788> for particulate matter when the device is labelled as low-particulate. Leachable assessment under ISO 10993-17 is required if a secondary lubricious coating or adhesive is applied inside the lumen. Terminal products include distal access microcatheter shafts, rapid exchange catheter shafts, and diagnostic angiography lumen components.

    What restricts nominal burst pressure when ME40 is coextruded as a balloon catheter inner lumen?

    Because the plasticised PA12 matrix has a lower yield stress than unplasticised PA12 or HDPE, the hoop stress capacity of a thin-wall inner lumen is governed by σ = P·ID/(2·t), where P is internal lumen pressure, ID is the lumen inner diameter, and t is the minimum wall thickness. For a lumen with 0.48 mm ID and 0.06 mm minimum wall, burst testing at 37 °C under ISO 10555-3 is mandatory; published data for this specific configuration is limited, so acceptance limits must be derived from the finished balloon catheter design, not from resin datasheet values. The single-lumen tube is extruded with a precision multi-pin die and in-line closed-loop wall measurement; concentricity within ±0.005 mm is required because the minimum wall governs burst. Melt temperature is kept between 200 °C and 230 °C, and a melt pump is used to damp pressure surge; the drawdown ratio is limited to 1.05 to 1.10 to avoid excessive orientation. The outer balloon layer is commonly polyether block amide or PA12; adhesion between ME40 and the balloon segment is not immediate on an as-extruded surface, so atmospheric plasma activation is used before application of UV-curable cyanoacrylate or light-curable polyurethane adhesive. Lap shear coupon testing under ASTM D1002 is used to characterise bond strength; cohesive failure within the adhesive is typically acceptable, while interfacial failure at the PA12 surface requires re-processing because surface contamination from the external lubricant package remains possible. Biocompatibility follows ISO 10993-4 for hemocompatibility, ISO 10993-6 for subchronic implantation if the catheter contact duration exceeds 30 days in the labelled use, and ISO 10555-4 for balloon catheter mechanical safety. Sterilisation is usually e-beam per ISO 11137-1; if gamma sterilisation is used, dose verification at 25 kGy to 40 kGy must include colour change and tensile retention because the plasticiser can respond to ionising radiation. Avoid processing above 235 °C where the thin wall becomes sensitive to melt fracture, and avoid blending with unplasticised PA12 regrind because viscosity mismatch causes weld-line weakness. Terminal products include balloon catheter inner lumens, inflation/deflation lumens, and reinforced tubing for rapid exchange catheters.

    Peristaltic Tubing Fatigue Under Asymmetric Roller Compression in Extracorporeal Lines

    In roller pump loops, the tubing segment is cyclically compressed between roller and raceway; the plasticised PA12 matrix provides recovery after repeated deformation but must be extruded with uniform wall thickness to avoid premature flexural fatigue. Typical pump-segment geometries fall between 3.2 mm and 6.4 mm outer diameter and 0.8 mm to 1.6 mm wall; the occlusion ratio is set by the pump head and is normally 10 % to 20 % of the inner diameter. Extrusion is carried out after pre-drying at 80 °C for 4 h to 6 h to ≤0.10 wt% moisture, with melt temperatures 200 °C to 230 °C, vacuum sizing, and cooling water controlled to 20 °C to 40 °C. After extrusion, tubes are conditioned at 23 °C and 50 % relative humidity for 48 h per ISO 291 before final ID, OD, and ovality verification because PA12 dimensions respond to moisture. Cycle fatigue testing is performed at 37 °C in isotonic saline at 1.5 Hz with a three-roller head as a screening method; published data for this specific grade under these exact cycle parameters is limited, so the replacement interval must be validated with the intended pump tube raceway, back pressure, and flow rate. The dominant failure mode is inner-surface crack initiation at the compression apex, not gross tensile rupture; optical inspection at ×10 magnification after 100 000 cycles can detect microcracking but is insufficient for lot release. Biocompatibility for blood-contacting lines includes ISO 10993-5, ISO 10993-11, USP <87>, and USP <88> Class VI; if ethylene oxide sterilisation is used, residual limits follow ISO 10993-7. The low moisture absorption of PA12 relative to PA6 and PA66 reduces aqueous swell and helps maintain roller occlusion consistency in long extracorporeal procedures. Terminal products include heart-lung machine pump segments, dialysis machine blood lines, and cardioplegia delivery tubing.

    Application segmentPrimary performance standardBiocompatibility chainSterilisation/validation reference
    Distal microcatheter shaftISO 10555-1ISO 10993-5, ISO 10993-10, ISO 10993-17ISO 11135 EtO, USP <788>
    Balloon catheter inner lumenISO 10555-4, ISO 10555-3ISO 10993-4, ISO 10993-6, ISO 10993-5ISO 11137-1 e-beam
    Peristaltic pump segmentUSP <88> Class VIISO 10993-5, ISO 10993-11, ISO 10993-7ISO 11135 EtO or ISO 11137-1
    Luer stopcock/manifoldISO 80369-7:2016ISO 10993-5, ISO 10993-10, ISO 10993-17ISO 17665-1 steam
    Overmolded torque handleDevice-specific torque/pull-out; no harmonised standardISO 10993-5, ISO 10993-10, ISO 10993-1:2018ISO 17665-1, ISO 14937
    Reusable orthopaedic handleISO 17665-1ISO 10993-5, ISO 10993-10ISO 17665-1, ISO 14937, ISO 15883

    Injection moulding of high-precision luer fittings from VESTAMID® Care ME40 begins with pre-drying at 80 °C for 4 h to 6 h; moisture must be ≤0.10 wt% to avoid splay, hydrolytic chain scission, and dimensional drift. Melt temperature is set from 230 °C to 250 °C, mould temperature 40 °C to 80 °C, holding pressure 40 MPa to 80 MPa, back pressure 5 MPa to 10 MPa, and screw rotation speed 50 rpm to 150 rpm. The use of a valve-gated hot runner with gate diameter 0.5 mm to 1.0 mm reduces gate vestige, which is critical for luer sealing. Regrind fraction should not exceed 20 wt% and must be re-dried and re-extruded under identical conditions because contamination and thermal history can affect molecular weight; any regrind lot requires a new cytotoxicity evaluation under ISO 10993-5. Colour concentrate should use a PA12-carrier medical masterbatch at ≤2 wt%; PE- or PP-based masterbatches form immiscible domains and can delaminate at thin sealing surfaces. Mould shrinkage after conditioning at 23 °C and 50 % relative humidity for 48 h per ISO 291 is typically 0.8 % to 1.2 % for unfilled grades; the specified gap and interference dimensions of ISO 80369-7:2016 luer connectors require shrinkage compensation via holding pressure and gate position. Repeated autoclaving at 121 °C can produce dimensional increases of 0.3 % to 0.6 % after a single cycle because of absorbed water; thread fit and torque-to-disconnect must be re-gauged after the maximum labelled reprocessing cycle. Biocompatibility for luer stopcocks and manifolds includes ISO 10993-5 and ISO 10993-10; leachables evaluation per ISO 10993-17 is required for colour-compounded mouldings because the final material is no longer identical to the neat resin. Terminal products include three-way stopcocks, Luer-activated valves, rotating male luer collars, and manifold housings for pressure monitoring and infusion lines.

    When ME40 is overmolded onto 304V stainless steel hypotubes for torque response

    Because the plasticised PA12 matrix contains an external lubricant package and low surface energy, adhesion to passivated 304V stainless steel is not intrinsic. Surface preparation by low-pressure plasma or a silane-based primer is used before insert moulding; mechanical interlocking features such as knurled bands, swaged collars, or cross-drilled holes are required because the resin cannot bear torque alone in a shaft assembly. Insert preheating to 120 °C to 140 °C reduces premature melt chilling; melt temperature is maintained at 220 °C to 240 °C, mould temperature 50 °C to 80 °C, and packing pressure 40 MPa to 70 MPa. Cooling time is extended until the part ejection temperature is below 80 °C to avoid insert sink and post-mould warpage. Gate location is optimised to prevent jetting around the hypotube; a valve-gated hot runner with gate land 0.5 mm to 1.0 mm and balanced flow channels reduces gas traps at the metal insert interface. Axial pull-out and torsional slip are measured on a calibrated universal tester at 100 mm/min axial speed or 1 rev/min torsional speed; no harmonised standard exists for this specific overmould configuration, so acceptance criteria must be derived from the finished device torque specification. Published data for this exact grade-insert combination is limited, and destructive testing of preconditioned parts after steam sterilisation is mandatory. Biocompatibility includes ISO 10993-5, ISO 10993-10, and ISO 10993-1:2018; steam sterilisation at 134 °C is validated under ISO 17665-1, and hydrogen peroxide gas plasma under ISO 14937. Terminal products include haemostatic valve handles, rotatable torque device housings, electrophysiology catheter handles, and laparoscopic instrument grips.

    Conversion routeDrying requirementMelt temperatureTooling/auxiliary conditionCritical control
    Single-screw microcatheter shaft extrusion80 °C, 4–6 h, ≤0.10 wt% moisture200–230 °CL/D 24:1–30:1, barrier screw, melt pump, laser gaugeDrawdown 1.05–1.20, concentricity
    Twin-screw BaSO₄ compounding80 °C, 4–6 h200–240 °CL/D 36:1–44:1, vacuum 200–400 mbarFiller loading 10–20 wt%, dispersion
    Luer fitting injection moulding80 °C, 4–6 h230–250 °CHot runner, valve gate, mould 40–80 °CHold 40–80 MPa, shrinkage 0.8–1.2 %
    Steel hypotube overmoulding80 °C, 4–6 h220–240 °CInsert preheat 120–140 °C, mould 50–80 °CPacking 40–70 MPa, pull-out/torque slip
    Peristaltic tube extrusion80 °C, 4–6 h200–230 °CVacuum sizing, water 20–40 °CWall 0.8–1.6 mm, conditioning 23 °C/50 % RH 48 h

    Repeated Steam Sterilisation and Hydrolytic Embrittlement in Reusable Orthopaedic Handles

    A reusable orthopaedic handle moulded from unfilled VESTAMID® Care ME40 and subjected to 134 °C saturated steam in an ISO 17665-1 cycle shows measurable dimensional shift driven by water absorption. The PA12 base absorbs less moisture than PA6 or PA66, but plasticiser migration to the surface may occur after repeated cycles, producing whitening or a slightly tacky surface that must be assessed for cleanability and user grip. Tensile strength retention should be evaluated after the maximum number of reprocessing cycles stated in the device IFU; published data for this specific grade after 100 steam cycles is limited, so full functional testing is required instead of extrapolation from short-term water immersion. Mould shrinkage and residual stress control are critical: melt temperature is 230 °C to 250 °C, mould temperature 40 °C to 60 °C, and post-mould annealing at 80 °C for 2 h reduces internal stresses that can accelerate stress-corrosion cracking at sharp bosses and snap-fit undercuts. Volumetric swell after repeated autoclaving is commonly measured in the 0.4 % to 0.8 % range for conditioned PA12 mouldings; design clearances must be verified on the actual moulded part because local wall thickness and moisture conditioning influence the final geometry. Biocompatibility includes ISO 10993-5 and ISO 10993-10; repeated sterilisation validation follows ISO 17665-1 for steam and ISO 14937 for hydrogen peroxide gas plasma. Cleaning compatibility is tested under the ISO 15883 series if automated washer-disinfector cycles are specified; avoid strong oxidising acids and concentrated alkaline detergents because PA12 can exhibit environmental stress cracking at sharp corners. Terminal products include orthopaedic reamer handles, powered surgical tool housings, and trial stem handles.

    Free Quote

    Competitive Evonik VESTAMID® Care ME40 Medical Grade Nylon 12 prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    VESTAMID® Care ME40 is an unfilled medical-grade polyamide 12 (PA12) supplied by Evonik in pellet form. The grade belongs to the medium-viscosity range within the VESTAMID® Care portfolio and is specified for melt extrusion and injection molding of medical device components, particularly tubular catheters, fluid-management lines, and single-use device housings. PA12 is a semicrystalline aliphatic polyamide with a lower amide-group density than PA6 or PA66, which reduces equilibrium water uptake and improves dimensional stability in humid conditions. Under ISO 1183, the density of this material falls in the range 1.01–1.02 g/cm³. Dry-state Shore D hardness is typically 60–65 per ISO 868, and the melting temperature measured by ISO 11357-1/-3 lies between 174 °C and 178 °C. Equilibrium water absorption at 23 °C in distilled water is approximately 1.2–1.5% when tested according to ISO 62, compared with 9–10% for PA6 and 8–9% for PA66 under identical conditioning.

    How Does VESTAMID® Care ME40 Differ from General-Purpose PA12 and Lower-Viscosity Medical Polyamides?

    The primary distinction between VESTAMID® Care ME40 and non-medical PA12 grades is not the polymer chemistry itself but rather the controlled raw-material qualification, production segregation, testing documentation, and change-management discipline applied to the medical-grade supply chain. The material is placed in a portfolio intended for applications requiring biological evaluation under ISO 10993-1, with supplier supporting data commonly addressing cytotoxicity per ISO 10993-5 and sensitization or irritation per ISO 10993-10. Finished-device validation remains mandatory because the final sterilization method, wall thickness, residual monomer content, and processing history influence biocompatibility outcomes.

    Compared with lower-viscosity PA12 grades in the VESTAMID® Care ML range, the medium-viscosity characteristics of ME40 provide higher melt strength during free-diameter drawing, vacuum sizing, and over-extrusion of catheter shafts. Lower-viscosity grades are generally more suited to thin-wall injection molding and complex multi-cavity tooling, where melt penetration and fill pressure are limiting factors. In contrast, the medium-melt-viscosity position of ME40 reduces draw resonance and improves wall-thickness consistency in tubing extrusion, especially when combined with a gear pump and closed-loop diameter control.

    The product also differs from polyether block amide grades in the VESTAMID® Care PEBA family. PEBA materials typically exhibit Shore D hardness values below 60 and higher elongation at break with lower flexural modulus. VESTAMID® Care ME40 occupies a higher-modulus, still flexible PA12 position that can serve as a stiff outer jacket or as a transition layer between a soft PEBA lumen and a stiff polymer hub. This difference is relevant in multi-layer catheter construction, where layer-to-layer bonding and hardness gradients determine kink resistance and pushability.

    Extrusion Melt Rheology and Drying Thresholds for Tubular Components

    Pre-drying is operationally critical because PA12 absorbs moisture rapidly. The resin should be dried in a dehumidifying dryer at 80 °C for 4–6 h to achieve a residual moisture level below 0.10% as determined by Karl Fischer titration or ISO 15512. Extended drying beyond 12 h can cause yellowing and oxidative degradation at the pellet surface, especially if the dryer dew point exceeds -40 °C. On production-scale single-screw extruders with L/D 24 to L/D 30, the recommended barrel profile begins with a cooled feed throat at 40–60 °C, progresses through compression zones at 180–230 °C, and reaches a die set point of 210–240 °C. The melt temperature measured at the screw tip should not exceed 260 °C; above this threshold, oxidative chain scission accelerates and can produce gel particles, discoloration, and reduced burst strength in thin-wall tubing.

    A three-zone screw with compression ratio 2.5:1–3.5:1 is typical for PA12. A gear pump between the extruder and die reduces pressure pulsation and improves wall-thickness consistency, especially at line speeds above 50 m/min. Screen packs with 60–100 mesh are used to trap char particles and ungelled material. In injection molding, melt temperatures of 220–250 °C and mold temperatures of 40–80 °C are common. Mold temperature influences crystallization shrinkage and sink marks; higher mold temperatures within this range improve surface gloss and reduce molded-in stress but increase cycle time. The exact processing window for VESTAMID® Care ME40 must be optimized on the target line because screw geometry, residence-time distribution, and shear history alter the effective melt viscosity.

    For thin-wall medical tubing, excessive moisture creates surface defects such as splay, bubbles, and internal microvoids. At rates above the stable draw window, PA12 melts can exhibit melt fracture. A common production failure is wall-thickness oscillation caused by unstable draw ratio when the die land length is shorter than 10 times the die gap. Increasing land length or reducing draw-down ratio between 1.5:1 and 3:1 can stabilize the tube. Published data for VESTAMID® Care ME40-specific extrusion runs at production speeds above 100 m/min are limited, so commissioning trials should map dimensional variance against screw speed and puller speed using statistical process control.

    Annealing of semi-crystalline PA12 can be performed at 120–140 °C for 30–60 min to reduce residual stress and improve environmental stress-cracking resistance. However, annealing also increases crystallinity and may reduce impact toughness. For medical tubing that will be coiled and packaged, the tubing should be conditioned before annealing to prevent coil set. When the product is over-molded onto connectors, the insert should be preheated to avoid premature freezing of the PA12 melt at the interface; gate dimensions below 1.0 mm can create excessive shear heating and local thermal degradation.

    Sterilization compatibility for VESTAMID® Care ME40 is device-specific and must be established on finished product. The base resin is commonly evaluated for cytotoxicity per ISO 10993-5 and irritation/sensitization per ISO 10993-10. Gamma irradiation at doses up to 50 kGy is generally feasible for PA12, but the dose-to-property relationship is nonlinear. Published data specifically for VESTAMID® Care ME40 after gamma doses above 45 kGy are limited; therefore, elongation at break and color shift should be measured on sterilized representative assemblies before release. Steam autoclave cycles at 121 °C or 134 °C introduce both moisture and thermal energy, and can reduce stiffness temporarily while increasing dimensions until the material reaches a new moisture equilibrium. Ethylene oxide processing requires residual ethylene oxide and ethylene chlorohydrin testing according to ISO 10993-7, and the PA12 grade may require longer aeration than low-absorption materials because of its polar amide groups.

    When Hydrolytic Aging in Water-Bearing Environments Limits Service Life

    PA12 is more resistant to hydrolytic degradation than PA6 or PA66, but it is not an absolute hydrolysis barrier. Continuous contact with water at temperatures above 60 °C can reduce molecular weight over time, and the rate depends on pH, pressure, and dissolved oxygen. Device designers should not infer a service temperature directly from the 174–178 °C melting point. Under sustained load in a wet environment, environmental stress cracking can occur in the presence of aggressive polar solvents, strong acids, or hypochlorite-based disinfectants. Concentrated hydrochloric acid, formic acid, and phenols are incompatible with PA12 at elevated temperature. The material should not be used for long-term implant applications without device-specific data including hydrolytic aging, fatigue, and particulate-generation testing.

    At 23 °C/50% RH, PA12 reaches an equilibrium moisture content near 0.7–0.9%, lower than PA6 and PA66. This reduces the dry-to-moist stiffness shift but does not eliminate it. Tensile modulus and stress at yield may decrease by several percent in the conditioned state, while impact toughness generally increases. Dimensional changes in precision tubing can still occur. A tube with a 0.50 mm wall thickness can change outside diameter by several percent when moving from dry-as-molded to saturated condition. Design tolerance analyses should use both dry and conditioned dimensions, and dimensional verification should be performed after conditioning per ISO 291 or the appropriate controlled-atmosphere standard.

    Multi-layer coextrusion lines with die gaps of 0.5–2.5 mm are used to produce VESTAMID® Care ME40 outer jackets over PTFE liners or PEBA inner layers for catheter shafts. The PA12 outer layer is selected where the design requires a balance of burst strength, kink resistance, and lower moisture swell than polyamide alternatives. Braided catheter shafts often combine 0.001–0.003 in stainless steel wire with a 40–70 Shore D outer jacket, and the 60–65 Shore D range of VESTAMID® Care ME40 permits over-melt bonding to tie-layer resins during coextrusion. Radial collapse pressure and burst pressure are measured according to ISO 10555 on finished catheter assemblies, not on pellet specimens. Published burst-pressure data for VESTAMID® Care ME40-specific catheter designs are limited; manufacturers should generate process-specific pressure and kink-resistance data on the intended production line.

    Test propertyStandard designationTypical range for medium-viscosity medical PA12
    DensityISO 11831.01–1.02 g/cm³
    Tensile modulus, dryISO 527-1/-2400–500 MPa
    Tensile stress at yield, dryISO 527-1/-230–35 MPa
    Nominal strain at break, dryISO 527-1/-2>200%
    Shore D hardness, dryISO 86860–65
    Vicat softening temperature, A50ISO 306155–165 °C
    Melting temperatureISO 11357-1/-3174–178 °C
    Water absorption, saturation at 23 °CISO 621.2–1.5%

    Comparisons with other medical-grade polymers should be made at equivalent moisture conditioning. A dry PA12 specimen will not represent the mechanical behavior of a conditioned catheter lumen in service. VESTAMID® Care ME40 is therefore not a universal replacement for PA6, PA66, PEBA, or thermoplastic polyurethane. Its selection is justified where a device requires reduced moisture uptake relative to PA6/PA66, lower density than polyamide alternatives, and sufficient flexural stiffness for pushable but kink-resistant tubing.

    Top